SCHEMBL2807104

SCHEMBL2807104

CCOC(=O)N1CC=C(c2cccc(-c3ccccc3)c2)CC1

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.58
TDP1 Q9NUW8 2/20 0.58
KDM4E B2RXH2 2/20 0.58
MAPT P10636 2/20 0.58
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
SMN1; SMN2 Q16637 2/20 0.49
NPC1 O15118 1/20 0.49
ALOX15 P16050 1/20 0.49
TSHR P16473 1/20 0.49
RAB9A P51151 1/20 0.49
KCNH2 Q12809 1/20 0.48
HRH3 Q9Y5N1 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.46
LMNA P02545 1/20 0.46
GAA P10253 1/20 0.45
P2RY12 Q9H244 1/20 0.45
QDPR P09417 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2811392 0.84 PDK4 (0.60) ALDH1A1MEN1KMT2ASMN1; SMN2NPC1
SCHEMBL14282249 0.83 ALDH1A1 (0.51) ALDH1A1TDP1KDM4EMAPTMEN1
SCHEMBL10236206 0.83 LNPEP (0.54) ALDH1A1TDP1KDM4EMAPTMEN1
SCHEMBL5959136 0.83 ALDH1A1 (0.57) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL14144348 0.81 ALDH1A1 (0.54) ALDH1A1TDP1KDM4EMAPTMEN1
SCHEMBL14379122 0.81 ALDH1A1 (0.56) ALDH1A1TDP1KDM4EMAPTMEN1
SCHEMBL4775621 0.80 MEN1 (0.61) ALDH1A1TDP1KDM4EMAPTMEN1
SCHEMBL14348177 0.79 ALDH1A1 (0.51) ALDH1A1TDP1KDM4EMAPTMEN1
SCHEMBL8315932 0.79 MEN1 (0.57) ALDH1A1TDP1KDM4EMAPTMEN1
SCHEMBL442073 0.78 ALDH1A1 (0.62) ALDH1A1TDP1KDM4EMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362040-B2 4-phenylpiperidine derivatives as renin inhibitors NOVARTIS AG (CH) 2013-01-29 US disclosed
US-20100240679-A1 4-Phenylpiperidine Derivatives as Renin Inhibitors NOVARTIS AG (CH) 2010-09-23 US disclosed
US-7754727-B2 4-phenylpiperidine derivatives as renin inhibitors NOVARTIS AG (CH) 2010-07-13 US disclosed
EP-1689712-B1 4-PHENYLPIPERIDINE DERIVATIVES AS RENIN INHIBITORS NOVARTIS AG (CH) 2009-08-19 EP disclosed
US-20080269255-A1 4-Phenylpiperidine Derivatives as Renin Inhibitors NOVARTIS AG (CH) 2008-10-30 US disclosed
US-20070078164-A1 4-Phenylpiperidine derivatives as renin inhibitors SEDRANI RICHARD 2007-04-05 US disclosed
EP-1689712-A1 4-PHENYLPIPERIDINE DERIVATIVES AS RENIN INHIBITORS Novartis AG (CH) 2006-08-16 EP disclosed
WO-2005051911-A1 4-PHENYLPIPERIDINE DERIVATIVES AS RENIN INHIBITORS NOVARTIS AG (CH) 2005-06-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269255-A1 4-Phenylpiperidine Derivatives as Renin Inhibitors REN, AGTR1, ACE ALDH1A1 417/4885TDP1 1241/4885KDM4E 3162/4885
US-20100240679-A1 4-Phenylpiperidine Derivatives as Renin Inhibitors REN, AGTR1, ACE ALDH1A1 466/4885TDP1 1418/4885KDM4E 3091/4885
US-20070078164-A1 4-Phenylpiperidine derivatives as renin inhibitors REN, AGTR1, ACE ALDH1A1 466/4885TDP1 1418/4885KDM4E 3091/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.